Thema: KYG596651029
MGTX, KYG596651029
dollar-2891842_1920.jpg - Foto: THN
MeiraGTx stock: New gene-therapy data span eye, ALS and xerostomia
MeiraGTx stock is in focus after new gene-therapy research in ALS, retinal disease and xerostomia. Lang & Schwarz showed 8.68 euros late on October 29.
ad-hoc-news.de, heute 01:10 Uhr
MGTX, KYG596651029
Nine analysts set USD 24.71 target for MeiraGTx stock
Second-quarter revenue reached USD 321.43 million versus USD 0.70 million. MeiraGTx stock costs EUR 9.00 on October 20, 2026 at 10:12 p.m. CEST.
ad-hoc-news.de, 20.10.26 20:18 Uhr
MGTX, KYG596651029
Nine analysts set USD 24.71 target for MeiraGTx stock
Revenue hit USD 321.43 million in second-quarter 2026. MGTX stock traded at USD 9.28 on October 16, 2026, down 6.17 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 18:52 Uhr
MGTX, KYG596651029
MeiraGTx stock rises to EUR 8.78 volume 39.05 percent below ...
Its 52-week range was USD 6.62 to USD 15.35 on October 15, 2026. MeiraGTx stock costs EUR 8.78 on October 15, 2026, up 4.36 percent on Nasdaq.
ad-hoc-news.de, 15.10.26 21:27 Uhr
MGTX, KYG596651029
MeiraGTx appoints Sebulsky: 9 analysts rate MeiraGTx stock ...
Nine analysts set a USD 24.71 average target on October 2, 2026. MeiraGTx stock costs EUR 9.73 on October 5, 2026 after EUR 9.65, plus 0.83 percent.
ad-hoc-news.de, 05.10.26 11:27 Uhr
MGTX, KYG596651029
Goldman Sachs starts MeiraGTx coverage with a USD 16 target ...
